@FierceMedDev: Corning leads NinePoint's new $34M Series B--a big round for the next-gen imaging tech developer. More | Follow @FierceMedDev
@MarkHFierce: This is the kind of pacer I'd like to try. Wild stuff. Feature via PopSci | Follow @MarkHFierce
@MichaelGFierce: Drug delivery in space? NASA contributes to the field with microcapsules developed by ISS Research. More via FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Congress wants more answers from the FDA about its regulation of mobile medical apps. Story | Follow @EmilyWFierce
> Abiomed ($ABMD) has completed enrollment in an IDE study for its Impella RP percutaneous heart pump. Release
> ProTom International in Texas gained 510(k) clearance for a new proton therapy device to treat patients with cancer. Release
> China is tightening its medical device regulatory supervision and enforcement. Item
> Medrobotics in Massachusetts gained a CE mark approval for its new robot-assisted surgical device designed for otolaryngology surgery. Story
> A group of UCSF researchers has come up with a wireless device that can be inserted into a pregnant woman's vagina and send an alert when premature labor may be happening. Story
Biotech News
@FierceBiotech: Biotechs bag $170M in IPO cash as a booming quarter winds down. Article | Follow @FierceBiotech
@JohnCFierce: Sanofi launches a vaccine R&D program with blockbuster Prevnar 13 in its sights. News | Follow @JohnCFierce
@DamianFierce: Liver risks put another Geron trial on ice, but the damage has largely been done already. More | Follow @DamianFierce
@EmilyMFierce: Survey: 1 in 5 Americans think doctors know vaccines cause autism. Story via FierceVaccines | Follow @EmilyMFierce
> GlaxoSmithKline's cancer vaccine MAGE-A3 suffers its second PhIII flop. More
> Sanofi launches a vaccine R&D program with blockbuster Prevnar 13 in its sights. Coverage
Pharma News
@FiercePharma: Pay-for-delay: Is cash the only antitrust test that matters in patent settlements? Story | Follow @FiercePharma
@TracyStaton: Should gastro specialist Salix snap up Furiex and its IBS drug candidate? More | Follow @TracyStaton
@EricPFierce: Even an OTC drugmaker can have research published in New England Journal of Medicine. News | Follow @EricPFierce
@CarlyHFierce: Valeant's CEO, a crackerjack cost-cutter, seeks more 'fat' companies to buy. Piece | Follow @CarlyHFierce
> J&J blazes a new pharma trail with industry's first designer-in-chief. Article
> AstraZeneca unveils direct-to-patient Nexium sales to fend off generic rivals. More
Pharma Manufacturing News
> Novartis CEO predicts generic industry fallout as quality takes center stage. Story
> FDA jumps compounder for making unapproved domperidone. News
> FDA cuts U.S. plant inspections while boosting them overseas. Story
> Indian regulator finds number of substandard drugs on the rise. Article
> Parexel opens Singapore distribution facility. Story
> OTC maker has discovery published in New England Journal of Medicine. Brief
Vaccines News
> Novartis to submit Bexsero to FDA in Q2. News
> 1 in 5 Americans think doctors know vaccines cause autism. Survey
> Amgen posts positive PhIII data as judgment day for cancer vaccine bet nears. News
> Failure of sexual health clinics to offer HPV vaccine leaves high-risk groups vulnerable. Story
> Circassia begins trading in London following successful IPO. News
> Sanofi inks a Korean alliance to develop a pneumococcal vaccine. Brief